Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
European Urology Open Science
|
April 17, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry
Steven M Monda, Eugene Oh, Patrick J Lewicki, et al.
Elife
|
May 17, 2022
Integrative analysis of scRNA-seq and scATAC-seq revealed transit-amplifying thymic epithelial cells expressing autoimmune regulator
Takahisa Miyao, Maki Miyauchi, S Thomas Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 6, 2025
The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis
Joanna A Vuille, Cem Tanriover, Ezgi Antmen, et al.
Nature Communications
|
June 28, 2019
Noncoding dsRNA induces retinoic acid synthesis to stimulate hair follicle regeneration via TLR3
Dongwon Kim, Ruosi Chen, Mary Sheu, et al.
Urologic Oncology
|
October 28, 2025
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study
Tanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
The Oncologist
|
October 7, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, et al.
Clinical Genitourinary Cancer
|
February 5, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database
Albert Jang, Tanya Jindal, Ali Raza Khaki, et al.
European Urology
|
September 15, 2025
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
Tanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
Cancer Medicine
|
October 1, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
Amanda Nizam, Charles B Nguyen, Jinju Li, et al.
International Forum of Allergy & Rhinology
|
March 14, 2026
Determining the Minimal Clinically Important Difference of the 40-Item Smell Identification Test in People With Cystic Fibrosis
Eugene Oh, Jessa E Miller, Michelle J Lee, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
European Urology Open Science
|
April 17, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry
Steven M Monda, Eugene Oh, Patrick J Lewicki, et al.
Elife
|
May 17, 2022
Integrative analysis of scRNA-seq and scATAC-seq revealed transit-amplifying thymic epithelial cells expressing autoimmune regulator
Takahisa Miyao, Maki Miyauchi, S Thomas Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 6, 2025
The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis
Joanna A Vuille, Cem Tanriover, Ezgi Antmen, et al.
Nature Communications
|
June 28, 2019
Noncoding dsRNA induces retinoic acid synthesis to stimulate hair follicle regeneration via TLR3
Dongwon Kim, Ruosi Chen, Mary Sheu, et al.
Urologic Oncology
|
October 28, 2025
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study
Tanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
The Oncologist
|
October 7, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, et al.
Clinical Genitourinary Cancer
|
February 5, 2026
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database
Albert Jang, Tanya Jindal, Ali Raza Khaki, et al.
European Urology
|
September 15, 2025
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
Tanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
Cancer Medicine
|
October 1, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
Amanda Nizam, Charles B Nguyen, Jinju Li, et al.
International Forum of Allergy & Rhinology
|
March 14, 2026
Determining the Minimal Clinically Important Difference of the 40-Item Smell Identification Test in People With Cystic Fibrosis
Eugene Oh, Jessa E Miller, Michelle J Lee, et al.
Page
of 7